2Luppa, M, Sikorski, C, Luck, T, Ehreke, L, Konnopka, A, Wiese, B, et al. Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis. J Affect Disord 2012; 136(3): 212–21.
4Manetti, A, Hoertel, N, Le Strat, Y, Schuster, J-P, Lemogne, C, Limosin, F. Comorbidity of late-life depression in the United States: a population-based study. Am J Geriatr Psychiatry 2014; 22(11): 1292–306.
5Gleason, OC, Pierce, AM, Walker, AE, Warnock, JK. The two-way relationship between medical illness and late-life depression. Psychiatr Clin North Am 2013; 36(4): 533–44.
6Brown, L, Karmakar, C, Gray, R, Jindal, R, Lim, T, Bryant, C. Heart rate variability alterations in late life depression: a meta-analysis. J Affect Disord 2018; 235: 456–66.
7Nelson, JC, Delucchi, K, Schneider, LS. Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence. Am J Geriatr Psychiatry 2008; 16(7): 558–67.
8Kok, RM, Reynolds, CF III. Management of depression in older adults: a review. JAMA 2017; 317(20): 2114–22.
9Nezafati, MH, Vojdanparast, M, Nezafati, P. Antidepressants and cardiovascular adverse events: a narrative review. ARYA Atheroscler 2015; 11(5): 295–304.
10Walton, KG, Schneider, RH, Nidich, SI, Salerno, JW, Nordstrom, CK, Bairey Merz, CN. Psychosocial stress and cardiovascular disease part 2: effectiveness of the transcendental meditation program in treatment and prevention. Behav Med 2002; 28(3): 106–23.
11Brook, RD, Appel, LJ, Rubenfire, M, Ogedegbe, G, Bisognano, JD, Elliott, WJ, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association. Hypertension 2013; 61(6): 1360–83.
13Lecrubier, Y, Sheehan D, V, Weiller, E, Amorim, P, Bonora, I, Harnett Sheehan, K, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12(5): 224–31.
14Zimmerman, M, Martinez, JH, Young, D, Chelminski, I, Dalrymple, K. Severity classification on the Hamilton Depression Rating Scale. J Affect Disord 2013; 150(2): 384–8.
15Folstein, MF, Folstein, SE, McHugh, PR. ‘Mini-Mental State’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189–98.
16Hillebrand, S, Gast, KB, de Mutsert, R, Swenne, CA, Jukema, JW, Middeldorp, S, et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Eurospace 2013; 15(5): 742–9.
17Busner, J, Targum, SD. The Clinical Global Impressions Scale: applying a research tool in clinical practice. Psychiatry 2007; 4(7): 28–37.
18Pachana, NA, Byrne, GJ, Siddle, H, Koloski, N, Harley, E, Arnold, E. Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr 2007; 19(1): 103–14.
19Washburn, RA, Smith, KW, Jette, AM, Janney, CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 1993; 46(2): 153–62.
20Raphael, D, Brown, I, Renwick, R, Cava, M, Weir, N, Heathcote, K. Measuring the quality of life of older persons: a model with implications for community and public health nursing. Int J Nurs Stud 1997; 34(3): 231–9.
21Vanderkooy, JD, Kennedy, SH, Bagby, RM. Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry 2002; 47(2): 174–80.
22Parmelee, PA, Thuras, PD, Katz, IR, Lawton, MP. Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc 1995; 43(2): 130–7.
23Lohr, S, Schochet, PZ, Sanders, E. Partially nested randomized controlled trials in education research: a guide to design and analysis. Natl Cent Educ Res 2014; 3129: 179.
24Nijjar, PS, Puppala, VK, Dickinson, O, Duval, S, Duprez, D, Kreitzer, MJ, et al. Modulation of the autonomic nervous system assessed through heart rate variability by a mindfulness based stress reduction program. Int J Cardiol 2014; 177: 557–9.
25Toni, G, Belvederi Murri, M, Piepoli, M, Zanetidou, S, Cabassi, A, Squatrito, S, et al. Physical exercise for late-life depression: effects on heart rate variability. Am J Geriatr Psychiatry 2016; 24(11): 989–97.
26Chu, I-H, Wu, W-L, Lin, I-M, Chang, Y-K, Lin, Y-J, Yang, P-C. Effects of yoga on heart rate variability and depressive symptoms in women: a randomized controlled trial. J Altern Complement Med 2017; 23(4): 310–316.
27Pocklington, C. Review article depression in older adults. BJMP 2017; 10(1): a1007.
28Sgoifo, A, Carnevali, L, Alfonso, MdlA, Amore, M. Autonomic dysfunction and heart rate variability in depression. Stress 2015; 18(3): 343–52.
29Kaufman, ES, Bosner, MS, Bigger, JTJ, Stein, PK, Kleiger, RE, Rolnitzky, LM, et al. Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects. Am J Cardiol 1993; 72(1): 95–9.
30Istenes, I, Körei, AE, Putz, Z, Németh, N, Martos, T, Keresztes, K, et al. Heart rate variability is severely impaired among type 2 diabetic patients with hypertension. Diabetes Metab Res Rev 2014; 30(4): 305–12.
31Nicolini, P, Ciulla, MM, De Asmundis, C, Magrini, F, Brugada, P. The prognostic value of heart rate variability in the elderly, changing the perspective: from sympathovagal balance to chaos theory. Pacing Clin Electrophysiol 2012; 35(5): 622–38.
32Lenze, EJ, Mulsant, BH, Blumberger, DM, Karp, JF, Newcomer, JW, Anderson, SJ, et al. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet 2015; 386(10011): 2404–12.
33Wetherell, JL, Hershey, T, Hickman, S, Tate, SR, Dixon, D, Bower, ES, et al. Mindfulness-based stress reduction for older adults with stress disorders and neurocognitive difficulties: a randomized controlled trial. J Clin Psychiatry 2017; 78(7): e734–43.
34Wuthrich, VM, Rapee, RM. Randomised controlled trial of group cognitive behavioural therapy for comorbid anxiety and depression in older adults. Behav Res Ther 2013; 51(12): 779–86.
35Lavretsky, H, Alstein, LL, Olmstead, RE, Ercoli, LM, Riparetti-Brown, M, Cyr, NS, et al. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial. Am J Geriatr Psychiatry 2011; 19(10): 839–50.
36Lutz, A, Slagter, HA, Dunne, JD, Davidson, RJ. Attention regulation and monitoring in meditation. Trends Cogn Sci 2008; 12(4): 163–9.
37Lutz, A, Greischar, LL, Rawlings, NB, Ricard, M, Davidson, RJ. Long-term meditators self-induce high-amplitude gamma synchrony during mental practice. Proc Natl Acad Sci USA 2004; 101(46): 16369–73.
38Sedlmeier, P, Eberth, J, Schwarz, M, Zimmermann, D, Haarig, F, Jaeger, S, et al. The psychological effects of meditation: a meta-analysis. Psychol Bull 2012; 138(6): 1139–71.
39Quintana, DS. Statistical considerations for reporting and planning heart rate variability case-control studies. Psychophysiology 2017; 54(3): 344–9.